title: The role of therapeutic drug monitoring in individualizing immunosuppressive drug therapy: recent developments.
authors.affiliation: Abteilung Klinische Chemie, Georg-August-University Göttingen, Germany. moeller@med.uni-goettingen.de
authors.forename: Michael
authors.initials: M
authors.lastname: Oellerich
authors.forename: Victor W
authors.initials: VW
authors.lastname: Armstrong
mesh_terms: D016572:Cyclosporine / Q000493:pharmacokinetics; D016903:Drug Monitoring; D000068338:Everolimus; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D009173:Mycophenolic Acid / Q000493:pharmacokinetics; D016377:Organ Transplantation; D011494:Protein Kinases / Q000378:metabolism; D020123:Sirolimus / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D058570:TOR Serine-Threonine Kinases; D016559:Tacrolimus / Q000493:pharmacokinetics
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D000068338:Everolimus; D011494:Protein Kinases; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases; D009173:Mycophenolic Acid; D020123:Sirolimus; D016559:Tacrolimus